<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Science and Innovations in Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Science and Innovations in Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Наука и инновации в медицине</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2500-1388</issn><issn publication-format="electronic">2618-754X</issn><publisher><publisher-name xml:lang="en">FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">53107</article-id><article-id pub-id-type="doi">10.35693/2500-1388-2020-5-4-272-277</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Surgery</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Хирургия</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Myxoid adrenal cortical adenoma and isolated adrenal myelolipoma</article-title><trans-title-group xml:lang="ru"><trans-title>Миксоидная кортикальная аденома и изолированная миелолипома надпочечника</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2045-0044</contrib-id><name-alternatives><name xml:lang="en"><surname>Lisitsyn</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Лисицын</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor, Department of Faculty Surgery named after I.I. Grekov</p></bio><bio xml:lang="ru"><p>к.м.н., доцент кафедры факультетской хирургии им. И.И. Грекова</p></bio><email>aleksandr.lisitsyn@szgmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2329-0023</contrib-id><name-alternatives><name xml:lang="en"><surname>Zemlyanoi</surname><given-names>V. P.</given-names></name><name xml:lang="ru"><surname>Земляной</surname><given-names>В. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Professor, Head of the Department of Faculty Surgery named after I.I. Grekov</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, заведующий кафедрой факультетской хирургии им. И.И. Грекова</p></bio><email>aleksandr.lisitsyn@szgmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9352-4035</contrib-id><name-alternatives><name xml:lang="en"><surname>Velikanova</surname><given-names>L. I.</given-names></name><name xml:lang="ru"><surname>Великанова</surname><given-names>Л. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Professor, Head of the Research Laboratory of Chromatography</p></bio><bio xml:lang="ru"><p>д.б.н., профессор, заведующая научно-исследовательской лабораторией хроматографии</p></bio><email>aleksandr.lisitsyn@szgmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5206-3367</contrib-id><name-alternatives><name xml:lang="en"><surname>Bekhtereva</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Бехтерева</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor, pathologist of the pathological department of clinical-molecular morphology</p></bio><bio xml:lang="ru"><p>д.м.н., доцент, врач патологоанатомпатологоанатомического отделения клиническоймолекулярной морфологии</p></bio><email>aleksandr.lisitsyn@szgmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8292-8504</contrib-id><name-alternatives><name xml:lang="en"><surname>Shafigullina</surname><given-names>Z. R.</given-names></name><name xml:lang="ru"><surname>Шафигуллина</surname><given-names>З. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor of the Department of Endocrinology named after acad. V.G. Baranov</p></bio><bio xml:lang="ru"><p>к.м.н., доцент кафедры эндокринологии им. акад. В.Г. Баранова</p></bio><email>aleksandr.lisitsyn@szgmu.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">North-Western State Medical University named after I.I. Mechnikov</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Северо-Западный государственный медицинский университет имени И.И. Мечникова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-07" publication-format="electronic"><day>07</day><month>12</month><year>2020</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>272</fpage><lpage>277</lpage><history><date date-type="received" iso-8601-date="2020-12-06"><day>06</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-06"><day>06</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Lisitsyn A.A., Zemlyanoi V.P., Velikanova L.I., Bekhtereva I.A., Shafigullina Z.R.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Лисицын А.А., Земляной В.П., Великанова Л.И., Бехтерева И.А., Шафигуллина З.Р.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Lisitsyn A.A., Zemlyanoi V.P., Velikanova L.I., Bekhtereva I.A., Shafigullina Z.R.</copyright-holder><copyright-holder xml:lang="ru">Лисицын А.А., Земляной В.П., Великанова Л.И., Бехтерева И.А., Шафигуллина З.Р.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://innoscience.ru/2500-1388/article/view/53107">https://innoscience.ru/2500-1388/article/view/53107</self-uri><abstract xml:lang="en"><p><bold>Objectives </bold>– to reveal the clinical, morphological and hormonal characteristics of patients operated on for isolated adrenal myelolipoma and myxoid adenomas with adrenal myelolipoma.</p> <p><bold>Material and methods.</bold> The study was based on the results of examination of patients operated on for adrenal myelolipoma in the period from 2000 to 2015. During the study, the hormonal activity in patients with isolated and myxoid adrenal myelolipomas was analyzed. A pathomorphological and immunohistochemical study of the removed formations of the adrenal gland was performed. The article presents rare clinical observations of patients undergoing treatment in the clinic of E.E. Eichwald, North-Western State Medical University named after I.I. Mechnikov, with accidentally detected neoplasms, which were a combination of adenoma and myelolipoma of the adrenal gland.</p> <p><bold>Results. </bold>The occurrence of isolated myelolipomas and myxoid adenomas with myelolipoma among incidentalomas was 6.3% and 4.9%, respectively. The average age of patients with adrenal myelolipoma is 54.5 years. The ratio of women to men was 2:1. According to our data, four types of hormonal activity have been identified among myxoid formations of the adrenal gland. Type 1 is associated with Cushing's syndrome, type 2 is associated with Conn's syndrome, type 3 is associated with autonomic cortisol secretion, type 4 has no hormonal activity. Based on the results obtained by high-performance liquid chromatography (HPLC), 11â-hydroxylase deficiency was noted, and according to the study of the urine steroid profile by gas chromatography-mass spectrometry (GCMS), the signs of type 2 11â-hydroxysteroid dehydrogenase deficiency and an increase in 5á-reductase activity in patients with isolated adrenal myelolipoma were obtained.</p> <p><bold>Conclusion. </bold>The combination of adenoma with myelolipoma, as well as of adenoma, myelolipoma and cavernous hemangioma is a rare pathology, the diagnosis of which is based on the pathomorphological examination of the removed tumor. Myelolipoma as a part of adrenal adenoma is an incidentaloma, which can be of different sizes and is accompanied by hormonal dysfunction of the cells of the adrenal cortex. An uncertain intrascopic phenotype and hormonal activity of myxoid formations are the decisive factors in favor of surgical intervention.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель</bold> – провести клинико-морфологический и гормональный анализ оперированных больных с изолированными миелолипомами и миксоидными аденомами с миелолипомой надпочечника.</p> <p><bold>Материал и методы.</bold> В основу работы легли полученные результаты обследования оперированных больных с миелолипомами надпочечника за период с 2000 по 2015 г. Был проведен анализ гормональной активности изолированных и миксоидных миелолипом надпочечника. Выполнено патоморфологическое и иммуногистохимическое исследование удаленных образований надпочечника. В работе представлены редкие клинические наблюдения больных, проходивших лечение в клинике Э.Э. Эйхвальда СЗГМУ им. И.И. Мечникова со случайно выявленными образованиями, представленными комбинацией аденомы и миелолипомы надпочечника.</p> <p><bold>Результаты.</bold> Частота встречаемости изолированных миелолипом и миксоидных аденом с миелолипомой среди инциденталом составила 6,3% и 4,9% соответственно. Средний возраст больных с миелолипомой надпочечника равен 54,5 года. Соотношение между женщинами и мужчинами составило 2:1. На основании полученных данных выявлено четыре типа гормональной активности миксоидных образований надпочечника. 1 тип ассоциирован с синдромом Кушинга, 2 тип – с синдромом Конна, 3 тип – с автономной секрецией кортизола, 4 тип – без гормональной активности. На основании результатов, полученных методом высокоэффективной жидкостной хроматографии (ВЭЖХ), отмечена 11â-гидроксилазная недостаточность, а по данным исследования стероидного профиля мочи методом газовой хромато-масс-спектрометрии (ГХМС) получены признаки недостаточности 11â-гидроксистероиддегидрогеназы 2 типа и повышения активности 5á-редуктазы у больных с изолированной миелолипомой надпочечника.</p> <p><bold>Заключение. </bold>Ассоциации аденомы с миелолипомой, а также аденомы, миелолипомы и кавернозной гемангиомы являются редкой патологией, диагностика которой основана на патоморфологическом исследовании удаленной опухоли. Миелолипома в составе аденомы надпочечника является инциденталомой, которая может быть разного размера и сопровождаться гормональной дисфункцией клеток коркового слоя надпочечника. Неопределенный интраскопический фенотип и гормональная активность миксоидных образований являются решающими факторами в пользу хирургического вмешательства.</p></trans-abstract><kwd-group xml:lang="en"><kwd>adrenal myelolipoma</kwd><kwd>myxoid adrenal tumor</kwd><kwd>adrenal adenoma</kwd><kwd>endovideosurgical adrenalectomy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>миелолипома надпочечника</kwd><kwd>миксоидная опухоль надпочечника</kwd><kwd>аденома надпочечника</kwd><kwd>эндовидеохирургическая адреналэктомия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bokhari MR, Zulfiqar H, Garla VV. Adrenal Myelolipoma. Book from Stat Pearls Publishing, Treasure Island (FL). 2017. PMID: 28613782</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Decmann A, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018;59:7–15. doi: 10.1007/s12020-017-1473-4</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kim HJ. Adrenal myelolipoma in association with congenital adrenal hyperplasia. Endocrine. 2019;63:403–404. doi: 10.1007/s12020-018-1827-6</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gershuni VM, Bittner JG, Moley JF, Brunt LM. Adrenal Myelolipoma: Operative Indications and Outcomes. Journal of Laparoendoscopic Advanced Surgical Techniques. Part A. 2014;24(1):8–12. doi: 10.1089/lap.2013.0411</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Shenoy VG, Thota А, Shankar R, Desai MG. Adrenal myelolipoma: Controversies in its management. Indian Journal of Urology. 2015; 31(2): 94–101. doi: 10.4103/0970-1591.152807</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Shenoy VG, Thota А, Shankar R, Desai MG. Adrenal myelolipoma: Controversies in its management. Indian Journal of Urology. 2015;31(2):94–101. doi: 10.4103/0970-1591.152807</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zeng Z, Gu LJ, Zhou ZY, et al. Case Report Myxoid adrenocortical adenoma with a pseudoglandular pattern: a case report and literature review. International Journal of Clinical and Experimental Pathology. 2017;10(8):8908–8915. PMCID: PMC6965459</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Fırat C, Eryiğit S, Yener S, et al. Myelolipomatous changes within adrenocortical adenoma. Cukurova Medical Journal. 2019;44(3):1135–1138. doi: 10.17826/cumj.494051</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zorgdrager М, Pol R, Hemel В, Ginkel R. Giant adrenal myelolipoma: when trauma and oncology collide. British Medical Journal. Case Rep. 2014. doi: 10.1136/bcr-2014-204023</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Polyakova GA, Kalinin AP. Variants of adrenal myelolipoma and rare comorbidities. Al'manah klinicheskoj mediciny. 2014;32:105–111. (In Russ.). [Полякова Г.А., Калинин А.П. Варианты миелолипом надпочечника и редкие сочетанные заболевания. Альманах клинической медицины. 2014;32:105–111]. doi: 10.18786/2072-0505-2014-32-105-111</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Anthony KGV. Myelolipoma of the adrenal gland: A review and update of the literature. Pulsus Journal of Surgical. 2018;2(2):50–63.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Mhammedi WA, Ouslim H, Ouraghi A, et al. Adrenal myelolipoma: from tumorigenesis to management. Pan African Medical Journal. 2019;34:180. doi: 10.11604/pamj.2019.34.180.20891</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hsu SW, Shu K, Lee WC, et al. Adrenal myelolipoma: A 10-year single-center experience and literature review. The Kaohsiung Journal of Medical Sciences. 2012;28(7):377–382. doi: 10.1016/j.kjms.2012.02.005</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zeiger MA, Thompson GB, Duh QY, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocrine Practice. doi: 10.4158/EP.15.5.450</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Shen X, Qui Y, Zheng Y, Zhang S. Retroperitoneal laparoscopic liposuction for large adrenal myelolipomas: A report of nine cases. Journal of Laparoendoscopic and Advanced Surgical Techniques. 2012;22:578–580. doi: 10.1089/lap.2012.0113</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Cochetti G, Paladini A, Boni A, et al. Robotic treatment of giant adrenal myelolipoma: A case report and review of the literature. Molecular and clinical oncology. 2019;492–496. doi: 10.3892/mco.2019.1823</mixed-citation></ref></ref-list></back></article>
